Johnson & Johnson

做多

JNJ Strong buy

由neilshahh提供

Good earnings. Rising dividends for 52 years. Doing well in Biotech, an up and coming sector. Hopefully it will start doing some more small M&A deals and release the 10 blockbusters it said it will over the next 5 years.

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。